Ratings for GoodRx Holdings (NASDAQ:GDRX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. In the assessment of 12-month price targets, analysts unveil insights for GoodRx Holdings, presenting an average target of $9.67, a high estimate of $10.00, and a low estimate of $8.50. Marking an increase of 7.44%, the current average surpasses the previous average price target of $…